Related references
Note: Only part of the references are listed.Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease
John A. Hey et al.
CLINICAL PHARMACOKINETICS (2018)
Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data
Petr Kocis et al.
CNS DRUGS (2017)
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42/Aβ1-40 ratio - a cross-validation study against amyloid PET
Josef Pannee et al.
JOURNAL OF NEUROCHEMISTRY (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis
Kirsten L. Viola et al.
ACTA NEUROPATHOLOGICA (2015)
Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol
Ming Jin et al.
NEUROBIOLOGY OF DISEASE (2015)
Amyloid-beta and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus
Sanna-Kaisa Herukka et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Amyloid-Beta Oligomerization in Alzheimer Dementia versus High-Pathology Controls
Thomas J. Esparza et al.
ANNALS OF NEUROLOGY (2013)
A Key Role for Lysine Residues in Amyloid β-Protein Folding, Assembly, and Toxicity
Sharmistha Sinha et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Hugo Vanderstichele et al.
ALZHEIMERS & DEMENTIA (2012)
Evaluation of Coupling Reversed Phase, Aqueous Normal Phase, and Hydrophilic Interaction Liquid Chromatography with Orbitrap Mass Spectrometry for Metabolomic Studies of Human Urine
Tong Zhang et al.
ANALYTICAL CHEMISTRY (2012)
Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field
Devleena Shivakumar et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide
Tadafumi Hashimoto et al.
JOURNAL OF NEUROSCIENCE (2012)
ProDy: Protein Dynamics Inferred from Theory and Experiments
Ahmet Bakan et al.
BIOINFORMATICS (2011)
Low-n oligomers as therapeutic targets of Alzheimer's disease
Kenjiro Ono et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect
Richard J. Caselli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity
Kenji Usui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Francine Gervais et al.
NEUROBIOLOGY OF AGING (2007)
Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity:: a potent role for trimers
M Townsend et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Share Paper
